Role of alpha 2-plasmin inhibitor in the appearance of fibrinolytic activity during urokinase administration, and an evaluation of the optimal urokinase dosage

Thromb Res. 1979;16(3-4):393-400. doi: 10.1016/0049-3848(79)90086-0.
No abstract available

MeSH terms

  • Dose-Response Relationship, Drug
  • Endopeptidases / administration & dosage*
  • Fibrin / pharmacology
  • Fibrinogen
  • Fibrinolysis*
  • Humans
  • Plasminogen
  • Urokinase-Type Plasminogen Activator / administration & dosage*
  • alpha 1-Antitrypsin
  • alpha-2-Antiplasmin*
  • alpha-Macroglobulins

Substances

  • alpha 1-Antitrypsin
  • alpha-2-Antiplasmin
  • alpha-Macroglobulins
  • Fibrin
  • Fibrinogen
  • Plasminogen
  • Endopeptidases
  • Urokinase-Type Plasminogen Activator